Matches in SemOpenAlex for { <https://semopenalex.org/work/W2578797650> ?p ?o ?g. }
- W2578797650 endingPage "33" @default.
- W2578797650 startingPage "26" @default.
- W2578797650 abstract "The use of antibiotics is necessary to treat bacterial diseases. Determination of optimal dosage in the target animals is increasingly being recognized as vital for maximizing efficacy and minimizing the risk of resistance, so this study aimed to evaluate the pharmacokinetics/pharmacodynamics (PK/PD) of levofloxacin in broilers. Using a parallel study design, each group of animals (n = 20) received 5 mg/kg of levofloxacin intravenously (IV) and orally (PO). Plasma, serum and tissues were collected for PK and PD studies. Plasma concentrations of levofloxacin were determined by HPLC. Minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) were determined against E. coli, isolated in clinical broilers. Ex vivo antibacterial activity was evaluated using the time killing method. Mean values of terminal half-life for IV and PO groups were 6.93 and 8.09 h, respectively. Following oral administration, the peak plasma concentration was achieved at 0.88 h (Tmax). Mean value of oral bioavailability was 123.25%. Levofloxacin residues were found in all the tissues tested (muscle, liver, kidney and lung). Plasma concentration above 8 × MIC lead to eradication of E. coli (incubation period of 24 h). The results of ex vivo growth inhibition curves were consistent with the in vitro time-kill study. Levofloxacin showed dependent plasma concentration antibacterial activity against a clinical isolate of E. coli. According to the assessment of PK/PD relationship, administration of 5 mg/kg of levofloxacin seems to be effective in killing E. coli. Also, simulated optimal dose based on the ex vivo PK/PD approach was 2.9 mg/kg/day (bactericidal) to 4.3 mg/kg/day (eradication) PO against E. coli (MIC = 0.125 μg/ml)." @default.
- W2578797650 created "2017-01-26" @default.
- W2578797650 creator A5008250531 @default.
- W2578797650 creator A5023495687 @default.
- W2578797650 creator A5028272132 @default.
- W2578797650 creator A5032300944 @default.
- W2578797650 creator A5053154367 @default.
- W2578797650 creator A5067124963 @default.
- W2578797650 creator A5078954438 @default.
- W2578797650 creator A5083050109 @default.
- W2578797650 date "2017-06-01" @default.
- W2578797650 modified "2023-09-27" @default.
- W2578797650 title "Ex vivo antibacterial activity of levofloxacin against Escherichia coli and its pharmacokinetic profile following intravenous and oral administrations in broilers" @default.
- W2578797650 cites W1962928558 @default.
- W2578797650 cites W1963829371 @default.
- W2578797650 cites W1969128660 @default.
- W2578797650 cites W1977045304 @default.
- W2578797650 cites W1983411303 @default.
- W2578797650 cites W1991919256 @default.
- W2578797650 cites W1995821982 @default.
- W2578797650 cites W2009310588 @default.
- W2578797650 cites W2017136623 @default.
- W2578797650 cites W2018589208 @default.
- W2578797650 cites W2024616331 @default.
- W2578797650 cites W2034697164 @default.
- W2578797650 cites W2036487127 @default.
- W2578797650 cites W2047994548 @default.
- W2578797650 cites W2059989328 @default.
- W2578797650 cites W2068301725 @default.
- W2578797650 cites W2081243791 @default.
- W2578797650 cites W2090214881 @default.
- W2578797650 cites W2092348049 @default.
- W2578797650 cites W2095926637 @default.
- W2578797650 cites W2108310800 @default.
- W2578797650 cites W2111150338 @default.
- W2578797650 cites W2113717321 @default.
- W2578797650 cites W2120135710 @default.
- W2578797650 cites W2130334061 @default.
- W2578797650 cites W2131441897 @default.
- W2578797650 cites W2137545422 @default.
- W2578797650 cites W2137757771 @default.
- W2578797650 cites W2138701893 @default.
- W2578797650 cites W2138984944 @default.
- W2578797650 cites W2147264575 @default.
- W2578797650 cites W2150760368 @default.
- W2578797650 cites W2161028017 @default.
- W2578797650 cites W2505053798 @default.
- W2578797650 cites W4211003030 @default.
- W2578797650 doi "https://doi.org/10.1016/j.rvsc.2017.01.003" @default.
- W2578797650 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28113087" @default.
- W2578797650 hasPublicationYear "2017" @default.
- W2578797650 type Work @default.
- W2578797650 sameAs 2578797650 @default.
- W2578797650 citedByCount "21" @default.
- W2578797650 countsByYear W25787976502017 @default.
- W2578797650 countsByYear W25787976502018 @default.
- W2578797650 countsByYear W25787976502019 @default.
- W2578797650 countsByYear W25787976502020 @default.
- W2578797650 countsByYear W25787976502021 @default.
- W2578797650 countsByYear W25787976502022 @default.
- W2578797650 countsByYear W25787976502023 @default.
- W2578797650 crossrefType "journal-article" @default.
- W2578797650 hasAuthorship W2578797650A5008250531 @default.
- W2578797650 hasAuthorship W2578797650A5023495687 @default.
- W2578797650 hasAuthorship W2578797650A5028272132 @default.
- W2578797650 hasAuthorship W2578797650A5032300944 @default.
- W2578797650 hasAuthorship W2578797650A5053154367 @default.
- W2578797650 hasAuthorship W2578797650A5067124963 @default.
- W2578797650 hasAuthorship W2578797650A5078954438 @default.
- W2578797650 hasAuthorship W2578797650A5083050109 @default.
- W2578797650 hasBestOaLocation W25787976502 @default.
- W2578797650 hasConcept C111113717 @default.
- W2578797650 hasConcept C112705442 @default.
- W2578797650 hasConcept C150903083 @default.
- W2578797650 hasConcept C176947019 @default.
- W2578797650 hasConcept C181389837 @default.
- W2578797650 hasConcept C185592680 @default.
- W2578797650 hasConcept C202751555 @default.
- W2578797650 hasConcept C207001950 @default.
- W2578797650 hasConcept C26291073 @default.
- W2578797650 hasConcept C2777056448 @default.
- W2578797650 hasConcept C2781276175 @default.
- W2578797650 hasConcept C3019249092 @default.
- W2578797650 hasConcept C501593827 @default.
- W2578797650 hasConcept C55493867 @default.
- W2578797650 hasConcept C71924100 @default.
- W2578797650 hasConcept C86803240 @default.
- W2578797650 hasConcept C89423630 @default.
- W2578797650 hasConcept C98274493 @default.
- W2578797650 hasConceptScore W2578797650C111113717 @default.
- W2578797650 hasConceptScore W2578797650C112705442 @default.
- W2578797650 hasConceptScore W2578797650C150903083 @default.
- W2578797650 hasConceptScore W2578797650C176947019 @default.
- W2578797650 hasConceptScore W2578797650C181389837 @default.
- W2578797650 hasConceptScore W2578797650C185592680 @default.
- W2578797650 hasConceptScore W2578797650C202751555 @default.
- W2578797650 hasConceptScore W2578797650C207001950 @default.
- W2578797650 hasConceptScore W2578797650C26291073 @default.